This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rachelle Jacques
CEO at Enzyvant


Rachelle joined Enzyvant as CEO from Alexion Pharmaceuticals, Inc., where she most recently served as Senior Vice President and Global Franchise Head of Complement across therapeutic areas of hematology, nephrology, and neurology. She brings broad experience in US and Global commercial leadership, including multiple high-profile product launches in rare diseases. Previously, Rachelle was Vice President of US Hematology Marketing at Shire and Baxalta, and Vice President, Business Operations for the Global Bioscience Business Unit at Baxter International. Rachelle has lived and worked in the US, Belgium, and China. She started her career in finance and has a BA in Business Administration with an emphasis in accounting from Alma College. Rachelle also serves on the boards of Corbus Pharmaceuticals and Viela Bio.

Agenda Sessions

  • Cell and gene therapy: The key driver for success is figuring out the unique manufacturing process and how to scale to market. How are companies approaching this challenge?

    On Demand

Speakers at this event